Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
chronic kidney disease
3
×
clinical trials
europe blog main
3
×
europe top stories
fda
3
×
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abbvie
biofourmis
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
glaxosmithkline
immunotherapy
indiana blog main
indiana top stories
medical devices
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
type 2 diabetes
wisconsin blog main
wisconsin top stories
What
bio
companies
days
life
roundup
science
street
wall
week
abbvie’s
ahead
arrival
biofourmis
biotech
black
bucks
cancer
celebrate
chance
continue
corner
day
debut
diamond
diamond’s
forward
hasn’t
holiday
indication
industry
ipo
ipos
labor
leading
looking
mammoth
march
market
momentum
moves
Language
unset
Current search:
national
×
" chronic kidney disease "
×
fda
×
" europe blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More